{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T03:54:34Z","timestamp":1777002874048,"version":"3.51.4"},"posted":{"date-parts":[[2024,9,16]]},"group-title":"Transplantation","reference-count":25,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,9,16]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                <jats:sec>\n                  <jats:title>Importance<\/jats:title>\n                  <jats:p>Patients requiring allogeneic hematopoietic cell transplantation have variable likelihoods of identifying an 8\/8 HLA-matched unrelated donor. A Search Prognosis calculator can estimate the likelihood.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To determine if using a search algorithm based on donor search prognosis can result in similar incidence of transplant between patients Very Likely (&gt;90%) vs Very Unlikely (&lt;10%) to have a matched unrelated donor.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>This interventional trial utilized a Search Prognosis-based biologic assignment algorithm to guide donor selection. Trial enrollment from June 13, 2019-May 13, 2022; analysis of data as of September 7, 2023 with median follow-up post-evaluability of 14.5 months.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Settings<\/jats:title>\n                  <jats:p>National multi-center Blood and Marrow Transplantation Clinical Trials Network 1702 study of US participating transplant centers.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Participants<\/jats:title>\n                  <jats:p>Acute myeloid and lymphoid leukemias, myelodysplastic syndrome, Hodgkin\u2019s and non-Hodgkin\u2019s lymphomas, severe aplastic anemia, and sickle cell disease patients referred to participating transplant centers were invited to participate. 2225 patients were enrolled and 1751 were declared evaluable for this study. Patients were declared evaluable once it was determined no suitable HLA-matched related donor was available.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Intervention<\/jats:title>\n                  <jats:p>Patients assigned to the Very Likely arm were to proceed with matched unrelated donor, while Very Unlikely were to utilize alternative donors. A third stratum, Less Likely (\u223c25%) to find a matched unrelated donor, were observed under standard center practices, but were not part of the primary objective.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Main Outcome<\/jats:title>\n                  <jats:p>Cumulative incidence of transplantation by Search Prognosis arm<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Evaluable patients included 1751 of which 413 (24%) were from racial\/ethnic minorities. Search prognosis was 958 (55%) Very Likely, 517 (30%) Less Likely and 276 (16%) Very Unlikely. 1171 (67%) received HCT, 384 (22%) died without HCT, and 196 (11%) remained alive without HCT. Among the 1,234 patients, the adjusted cumulative incidence (95% CI) of HCT at 6-months was 59.8% (56.7-62.8) in the Very Likely group versus 52.3% (46.1-58.5) in the Very Unlikely (P=0.113).<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>A prospective Search Prognosis-based algorithm can be effectively implemented in a national multicenter clinical trial. This approach resulted in rapid alternative donor identification and comparable rates of HCT in patients Very Likely and Very Unlikely to find a matched unrelated donor.<\/jats:p>\n                  <jats:p>\n                    <jats:bold>Trial Registration:<\/jats:bold>\n                    NCT#03904134\n                  <\/jats:p>\n                <\/jats:sec>","DOI":"10.1101\/2024.09.16.24313494","type":"posted-content","created":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T16:00:21Z","timestamp":1726761621000},"source":"Crossref","is-referenced-by-count":6,"title":["Access to Allogeneic Cell Transplantation Based on Donor Search Prognosis: An Interventional Trial"],"prefix":"10.64898","author":[{"given":"Jason G.","family":"Dehn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brent","family":"Logan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bronwen E.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Devine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan O.","family":"Ciurea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Horowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naya","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iskra","family":"Pusic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samer A.","family":"Srour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally","family":"Arai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Juckett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Uberti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LaQuisa","family":"Hill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumithira","family":"Vasu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5841-4105","authenticated-orcid":false,"given":"William J.","family":"Hogan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brandon","family":"Hayes-Lattin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Westervelt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asad","family":"Bashey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nosha","family":"Farhadfar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael R.","family":"Grunwald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Leifer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Symons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayman","family":"Saad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenny","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Connor","family":"Erickson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"Buck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Pidala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"issue":"3","key":"2024091913001194000_2024.09.16.24313494v1.1","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1016\/S2352-3026(15)00028-9","article-title":"One million haemopoietic stem-cell transplants: a retrospective observational study","volume":"2","year":"2015","journal-title":"Lancet Haematol"},{"issue":"6","key":"2024091913001194000_2024.09.16.24313494v1.2","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/bmt.2017.34","article-title":"Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report","volume":"52","year":"2017","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"2024091913001194000_2024.09.16.24313494v1.3","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.bbmt.2015.09.012","article-title":"On Modeling Human Leukocyte Antigen-Identical Sibling Match Probability for Allogeneic Hematopoietic Cell Transplantation: Estimating the Need for an Unrelated Donor Source","volume":"22","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"2024091913001194000_2024.09.16.24313494v1.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2008.05.017"},{"key":"2024091913001194000_2024.09.16.24313494v1.5","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019001212"},{"key":"2024091913001194000_2024.09.16.24313494v1.6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-05-576041"},{"key":"2024091913001194000_2024.09.16.24313494v1.7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-06-097386"},{"key":"2024091913001194000_2024.09.16.24313494v1.8","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-09-381699"},{"key":"2024091913001194000_2024.09.16.24313494v1.9","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-04-496778"},{"issue":"11","key":"2024091913001194000_2024.09.16.24313494v1.10","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1016\/j.bbmt.2019.06.031","article-title":"Comparable Long-Term Outcome after Allogeneic Stem Cell Transplantation from Sibling and Matched Unrelated Donors in Patients with Acute Myeloid Leukemia Older Than 50 Years: A Report on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation","volume":"25","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"2024091913001194000_2024.09.16.24313494v1.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2014.10.002"},{"issue":"4","key":"2024091913001194000_2024.09.16.24313494v1.12","first-page":"339","article-title":"HLA match likelihoods for hematopoietic stem-cell grafts in the U","volume":"371","year":"2014","journal-title":"S. registry. N Engl J Med"},{"issue":"15","key":"2024091913001194000_2024.09.16.24313494v1.13","doi-asserted-by":"crossref","first-page":"3824","DOI":"10.1182\/bloodadvances.2022008572","article-title":"Analysis of disparities in time to allogeneic transplantation in adults with acute myelogenous leukemia","volume":"7","year":"2023","journal-title":"Blood Adv"},{"key":"2024091913001194000_2024.09.16.24313494v1.14","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2012.150"},{"issue":"2","key":"2024091913001194000_2024.09.16.24313494v1.15","first-page":"184 e181","article-title":"Likelihood of Proceeding to Allogeneic Hematopoietic Cell Transplantation in the United States after Search Activation in the National Registry: Impact of Patient Age, Disease, and Search Prognosis","volume":"27","year":"2021","journal-title":". Transplant Cell Ther"},{"issue":"18","key":"2024091913001194000_2024.09.16.24313494v1.16","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1200\/JCO.20.03502","article-title":"National Marrow Donor Program-Sponsored Multicenter, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation Using Post-Transplant Cyclophosphamide","volume":"39","year":"2021","journal-title":"J Clin Oncol"},{"issue":"3","key":"2024091913001194000_2024.09.16.24313494v1.17","first-page":"208 e201","article-title":"Three-Year Outcomes in Recipients of Mismatched Unrelated Bone Marrow Donor Transplants Using Post-Transplantation Cyclophosphamide: Follow-Up from a National Marrow Donor Program-Sponsored Prospective Clinical Trial","volume":"29","year":"2023","journal-title":"Transplant Cell Ther"},{"issue":"3","key":"2024091913001194000_2024.09.16.24313494v1.18","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1182\/blood.2021011281","article-title":"HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxis","volume":"138","year":"2021","journal-title":"Blood"},{"issue":"3","key":"2024091913001194000_2024.09.16.24313494v1.19","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1182\/blood.2020007535","article-title":"Double unrelated umbilical cord blood vs HLA-haploidentical bone marrow transplantation: the BMT CTN 1101 trial","volume":"137","year":"2021","journal-title":"Blood"},{"key":"2024091913001194000_2024.09.16.24313494v1.20","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-04-639831"},{"issue":"11","key":"2024091913001194000_2024.09.16.24313494v1.21","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1038\/bmt.2016.162","article-title":"Unrelated donor search prognostic score to support early HLA consultation and clinical decisions","volume":"51","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"2024091913001194000_2024.09.16.24313494v1.22","doi-asserted-by":"publisher","DOI":"10.1177\/1740774508098326"},{"issue":"3","key":"2024091913001194000_2024.09.16.24313494v1.23","first-page":"141","article-title":"An Empirical Transition Matrix for Non-Homogeneous Markov Chains Based on Censored Observations","volume":"5","year":"1978","journal-title":"Scandinavian Journal of Statistics"},{"key":"2024091913001194000_2024.09.16.24313494v1.24","doi-asserted-by":"publisher","DOI":"10.2307\/2670170"},{"key":"2024091913001194000_2024.09.16.24313494v1.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmpb.2010.07.005"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2024.09.16.24313494","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T20:12:06Z","timestamp":1768507926000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2024.09.16.24313494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,16]]},"references-count":25,"URL":"https:\/\/doi.org\/10.1101\/2024.09.16.24313494","relation":{},"subject":[],"published":{"date-parts":[[2024,9,16]]},"subtype":"preprint"}}